← Leaderboards
Jon Scott Thorson
Sloan-Kettering Institute For Cancer Res
$24,592,329
Attributed
$31,254,437
Total exposure
20
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$45,401,175 · 21
By mechanism
P20$19,054,414 · 4
R01$18,636,063 · 9
R37$4,005,420 · 1
R24$2,347,020 · 1
U19$1,228,870 · 1
P30$111,318 · 1
Top collaborators
- Steven Gary Van Lanen10 shared
- George Neal Phillips9 shared
- Bernard Mark Evers5 shared
- Peixuan Guo5 shared
- Qing-Bai She5 shared
- Stephen Randal Voss4 shared
Others in their field
Top investigators on “Innovation”
- David R. Weir · University Of Michigan At Ann Arbor$382,307,654
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$319,874,172
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$311,654,401
- Richard A Gibbs · Baylor College Of Medicine$300,634,418
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$271,752,220
Research focus
InnovationStructureIn VitroDesignBaseEnzymesCollaborationsEngineeringIn VivoProgramsLibrariesPre-ClinicalUniversitiesGlycosyltransferaseBiologicalComplexResearch PersonnelSugarNatural ProductsPharmacologic SubstanceReactionMolecularProductionAnalog
Grant awards (100)
COBRE for Translational Chemical Biology$2,309,998
P20 · FY2025 · GM · contact PI
Administrative Core$709,332
P20 · FY2025 · GM · contact PI
Center of Biomedical Research Excellence in Pharmaceutical Research and Innovation$2,260,084
P20 · FY2024 · GM · contact PI
Administrative Core$1,370,816
P20 · FY2024 · GM · contact PI
Center of Biomedical Research Excellence in Pharmaceutical Research and Innovation$2,260,084
P20 · FY2023 · GM · contact PI
Administrative Core$847,187
P20 · FY2023 · GM · contact PI
Administrative Supplement: COBRE in Pharmaceutical Research and Innovation$212,591
P20 · FY2023 · GM · contact PI
Center of Biomedical Research Excellence in Pharmaceutical Research and Innovation$2,260,084
P20 · FY2022 · GM · contact PI
Administrative Core$945,698
P20 · FY2022 · GM · contact PI
Administrative Supplement: COBRE in Pharmaceutical Research and Innovation$250,000
P20 · FY2022 · GM · contact PI
Center of Biomedical Research Excellence in Pharmaceutical Research and Innovation$2,260,084
P20 · FY2021 · GM · contact PI
Administrative Core$544,095
P20 · FY2021 · GM · contact PI
Studies to understand and exploit 10-membered enediyne biosynthesis$516,179
R01 · FY2021 · CA · contact PI
In Vitro Glycorandomization of Natural Products$445,994
R37 · FY2021 · AI · contact PI
Biosynthesis and medicinal chemistry of the capuramycin antimycobacterial antibiotics$200,000
R01 · FY2021 · AI
Administrative Supplement: COBRE in Pharmaceutical Research and Innovation$166,441
P20 · FY2021 · GM · contact PI
Center of Biomedical Research Excellence in Pharmaceutical Research and Innovation$2,167,372
P20 · FY2020 · GM · contact PI
Studies to understand and exploit 10-membered enediyne biosynthesis$516,179
R01 · FY2020 · CA · contact PI
Administrative Core$490,548
P20 · FY2020 · GM · contact PI
In Vitro Glycorandomization of Natural Products$442,195
R37 · FY2020 · AI · contact PI
Natural product-based modulators of 4E-BP1 phosphorylation$381,610
R01 · FY2020 · CA · contact PI
Biosynthesis and medicinal chemistry of the capuramycin antimycobacterial antibiotics$200,000
R01 · FY2020 · AI
Platform technologies for understanding and exploiting methylation$563,800
R01 · FY2019 · GM · contact PI
Developing Regeneration Resources for a Model Amphibian$557,910
R24 · FY2019 · OD
Studies to understand and exploit 10-membered enediyne biosynthesis$500,693
R01 · FY2019 · CA · contact PI
In Vitro Glycorandomization of Natural Products$438,459
R37 · FY2019 · AI · contact PI
Natural product-based modulators of 4E-BP1 phosphorylation$374,318
R01 · FY2019 · CA · contact PI
Novel pRNA Nanoparticle Delivery as Directed Therapy for Colorectal Cancer Metastasis$272,003
R01 · FY2019 · CA
Biosynthesis and medicinal chemistry of the capuramycin antimycobacterial antibiotics$200,000
R01 · FY2019 · AI
Drug Discovery, Delivery, and Translational Therapeutics Research Program$32,020
P30 · FY2019 · CA · contact PI
Developing Regeneration Resources for a Model Amphibian$557,910
R24 · FY2018 · OD
Platform technologies for understanding and exploiting methylation$547,502
R01 · FY2018 · GM · contact PI
Studies to understand and exploit 10-membered enediyne biosynthesis$516,179
R01 · FY2018 · CA · contact PI
In Vitro Glycorandomization of Natural Products$440,208
R37 · FY2018 · AI · contact PI
Natural product-based modulators of 4E-BP1 phosphorylation$391,163
R01 · FY2018 · CA · contact PI
Novel pRNA Nanoparticle Delivery as Directed Therapy for Colorectal Cancer Metastasis$280,416
R01 · FY2018 · CA
Biosynthesis and medicinal chemistry of the capuramycin antimycobacterial antibiotics$200,000
R01 · FY2018 · AI
Drug Discovery, Delivery, and Translational Therapeutics Research Program$32,020
P30 · FY2018 · CA · contact PI
Drug Discovery, Delivery, and Translational Therapeutics Research Program$15,119
P30 · FY2018 · CA · contact PI
Drug Discovery, Delivery, and Translational Therapeutics Research Program$13,346
P30 · FY2018 · CA · contact PI
Drug Discovery, Delivery, and Translational Therapeutics Research Program$12,500
P30 · FY2018 · CA · contact PI
Drug Discovery, Delivery, and Translational Therapeutics Research Program$6,313
P30 · FY2018 · CA · contact PI
Developing Regeneration Resources for a Model Amphibian$573,257
R24 · FY2017 · OD
Platform technologies for understanding and exploiting methylation$547,502
R01 · FY2017 · GM · contact PI
Studies to understand and exploit 10-membered enediyne biosynthesis$532,052
R01 · FY2017 · CA · contact PI
In Vitro Glycorandomization of Natural Products$436,964
R37 · FY2017 · AI · contact PI
Novel pRNA Nanoparticle Delivery as Directed Therapy for Colorectal Cancer Metastasis$404,050
R01 · FY2017 · CA
Natural product-based modulators of 4E-BP1 phosphorylation$395,652
R01 · FY2017 · CA · contact PI
Biosynthesis and medicinal chemistry of the capuramycin antimycobacterial antibiotics$200,000
R01 · FY2017 · AI
Developing Regeneration Resources for a Model Amphibian$657,943
R24 · FY2016 · OD
Platform technologies for understanding and exploiting methylation$563,894
R01 · FY2016 · GM · contact PI
Novel pRNA Nanoparticle Delivery as Directed Therapy for Colorectal Cancer Metastasis$411,046
R01 · FY2016 · CA
Natural product-based modulators of 4E-BP1 phosphorylation$391,220
R01 · FY2016 · CA · contact PI
In vitro glycorandomization of natural products$363,427
R37 · FY2016 · AI · contact PI
Novel pRNA Nanoparticle Delivery as Directed Therapy for Colorectal Cancer Metastasis$416,604
R01 · FY2015 · CA
In vitro glycorandomization of natural products$364,137
R37 · FY2015 · AI · contact PI
In vitro glycorandomization of natural products$364,783
R37 · FY2014 · AI · contact PI
In vitro glycorandomization of natural products$343,447
R37 · FY2013 · AI · contact PI
STUDIES ON CALICHEAMICIN BIOSYNTHESIS AND SELF RESISTANCE$263,268
R01 · FY2013 · CA · contact PI
In vitro glycorandomization of natural products$365,806
R37 · FY2012 · AI · contact PI
STUDIES ON CALICHEAMICIN BIOSYNTHESIS AND SELF RESISTANCE$280,072
R01 · FY2012 · CA · contact PI
In Vitro Glycorandomization of Natural Products$349,729
R01 · FY2011 · AI · contact PI
STUDIES ON CALICHEAMICIN BIOSYNTHESIS AND SELF RESISTANCE$281,768
R01 · FY2011 · CA · contact PI
DYNAMICS STUDY OF GLYCOSYLTRANSFERASE$15,936
P41 · FY2011 · RR · contact PI
ENGINEERING METHYLTRANSFERASE INVOLVED IN THE BIOSYNTHESIS OF AT2433$122
P41 · FY2011 · RR · contact PI
In Vitro Glycorandomization of Natural Products$353,261
R01 · FY2010 · AI · contact PI
STUDIES ON CALICHEAMICIN BIOSYNTHESIS AND SELF RESISTANCE$290,614
R01 · FY2010 · CA · contact PI
In Vitro Glycorandomization of Natural Products$237,082
R01 · FY2010 · AI · contact PI
In Vitro Glycorandomization of Natural Products$356,829
R01 · FY2009 · AI · contact PI
Glycorandomization/Neoglycorandomization for Anticancer Discovery$288,971
U19 · FY2009 · CA · contact PI
In Vitro Glycorandomization of Natural Products$356,829
R01 · FY2008 · AI · contact PI
Glycorandomization/Neoglycorandomization for Anticancer Discovery$284,196
U19 · FY2008 · CA · contact PI
Studies on Calicheamicin Biosynthesis and Resistance$275,409
R01 · FY2008 · CA · contact PI
Exocyclic C-C Modifications of Aromatic Polyketides$272,434
R01 · FY2008 · GM · contact PI
ENGINEERING METHYLTRANSFERASE INVOLVED IN THE BIOSYNTHESIS OF AT2433$1,884
P41 · FY2008 · RR · contact PI
In Vitro Glycorandomization of Natural Products$363,740
R01 · FY2007 · AI · contact PI
Glycorandomization/Neoglycorandomization for Anticancer Discovery$284,876
U19 · FY2007 · CA · contact PI
Studies on Calicheamicin Biosynthesis and Resistance$275,525
R01 · FY2007 · CA · contact PI
Exocyclic C-C Modifications of Aromatic Polyketides$272,535
R01 · FY2007 · GM · contact PI
THE THREE-DIMENSIONAL STRUCTURE OF CALC, A POTENT ANTIBIOTIC BINDING PROTEIN$128
P41 · FY2007 · RR · contact PI
In Vitro Glycorandomization of Natural Products$350,950
R01 · FY2006 · AI · contact PI
Studies on Calicheamicin Biosynthesis and Resistance$283,868
R01 · FY2006 · CA · contact PI
Exocyclic C-C Modifications of Aromatic Polyketides$280,777
R01 · FY2006 · GM · contact PI
Glycorandomization/Neoglycorandomization for Anticancer Discovery$186,796
U19 · FY2006 · CA · contact PI
In Vitro Glycorandomization of Natural Products$359,523
R01 · FY2005 · AI
Studies on Calicheamicin Biosynthesis and Resistance$290,815
R01 · FY2005 · CA
Exocyclic C-C Modifications of Aromatic Polyketides$287,634
R01 · FY2005 · GM
Glycorandomization/Neoglycorandomization for Anticancer Discovery$184,031
U19 · FY2005 · CA
In Vitro Glycorandomization of Natural Products$359,646
R01 · FY2004 · AI
Studies on Calicheamicin Biosynthesis and Resistance$290,926
R01 · FY2004 · CA
In Vitro Glycorandomization of Natural Products$359,766
R01 · FY2003 · AI
STUDIES ON CALICHEAMICIN BIOSYNTHESIS AND SELF RESISTANC$261,900
R01 · FY2003 · CA
In Vitro Glycorandomization of Natural Products$359,882
R01 · FY2002 · AI
STUDIES ON CALICHEAMICIN BIOSYNTHESIS AND SELF RESISTANC$261,900
R01 · FY2002 · CA
MECHANISTIC STUDIES OF PROKARYOTIC MANNOSYLTRANSFERASES$195,506
R01 · FY2002 · GM
STUDIES ON CALICHEAMICIN BIOSYNTHESIS AND SELF RESISTANC$240,075
R01 · FY2001 · CA
MECHANISTIC STUDIES OF PROKARYOTIC MANNOSYLTRANSFERASES$189,813
R01 · FY2001 · GM
STUDIES ON CALICHEAMICIN BIOSYNTHESIS AND SELF RESISTANC$24,615
R01 · FY2001 · CA
STUDIES ON CALICHEAMICIN BIOSYNTHESIS AND SELF RESISTANC$284,851
R01 · FY2000 · CA
MECHANISTIC STUDIES OF PROKARYOTIC MANNOSYLTRANSFERASES$202,459
R01 · FY2000 · GM